CN114656458A - Oxetane-modified isocyanurate compound, curing composition and application - Google Patents

Oxetane-modified isocyanurate compound, curing composition and application Download PDF

Info

Publication number
CN114656458A
CN114656458A CN202011536241.XA CN202011536241A CN114656458A CN 114656458 A CN114656458 A CN 114656458A CN 202011536241 A CN202011536241 A CN 202011536241A CN 114656458 A CN114656458 A CN 114656458A
Authority
CN
China
Prior art keywords
oxetane
modified isocyanurate
isocyanurate compound
compound
curing composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN202011536241.XA
Other languages
Chinese (zh)
Other versions
CN114656458B (en
Inventor
钱晓春
于培培
金晓蓓
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Changzhou Tronly New Electronic Materials Co Ltd
Changzhou Tronly Advanced Electronic Materials Co Ltd
Original Assignee
Changzhou Tronly New Electronic Materials Co Ltd
Changzhou Tronly Advanced Electronic Materials Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Changzhou Tronly New Electronic Materials Co Ltd, Changzhou Tronly Advanced Electronic Materials Co Ltd filed Critical Changzhou Tronly New Electronic Materials Co Ltd
Priority to CN202011536241.XA priority Critical patent/CN114656458B/en
Priority to PCT/CN2021/138911 priority patent/WO2022135275A1/en
Publication of CN114656458A publication Critical patent/CN114656458A/en
Application granted granted Critical
Publication of CN114656458B publication Critical patent/CN114656458B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G65/00Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • C08G65/02Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G65/00Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • C08G65/02Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
    • C08G65/04Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring from cyclic ethers only
    • C08G65/22Cyclic ethers having at least one atom other than carbon and hydrogen outside the ring
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08KUse of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K5/00Use of organic ingredients
    • C08K5/16Nitrogen-containing compounds
    • C08K5/34Heterocyclic compounds having nitrogen in the ring
    • C08K5/3467Heterocyclic compounds having nitrogen in the ring having more than two nitrogen atoms in the ring
    • C08K5/3477Six-membered rings
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08LCOMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L101/00Compositions of unspecified macromolecular compounds

Abstract

The invention provides an oxetane modified isocyanurate compound, a curing composition and application. The oxetane-modified isocyanurate compound has a structure shown in the following structural general formula (I),
Figure DDA0002853135960000011
wherein R is1、R2And R3Each independently selected from H,
Figure DDA0002853135960000012
Any one of (1), R1、R2And R3Not simultaneously being H or R4Is composed of
Figure DDA0002853135960000013
-any one of OH and R1、R2And R3R of (A) to (B)4Not simultaneously being-OH, and R5Each independently is a hydrogen atom, a methyl group or an ethyl group; r6Each independently selected from C1‑C20Linear alkylene of (2), C3‑C20N is 1, 2 or 3. When the compound with the structural general formula (I) is applied to a curing composition, the hardness and the flexibility of a cured product of the curing composition can be improved, and the advantage of excellent adhesion of an oxetane compound can be maintained.

Description

Oxetane-modified isocyanurate compound, curing composition and application
Technical Field
The invention relates to the field of curing materials, and particularly relates to an oxetane modified isocyanurate compound, a curing composition and application.
Background
The oxetane product has similar ring tension and higher alkalinity, but also shows longer induction period and low overall polymerization degree, and has the characteristics of small shrinkage rate during curing, mechanical property, heat resistance, weather resistance and excellent transparency. In view of such excellent characteristics, applications of oxetane compounds in the fields of coatings, paints, inks, adhesives, films, optical materials, sealants and the like have been reported. However, the hardness and flexibility of oxetane products have yet to be improved.
The isocyanurate compound has good thermal stability, flame retardance and chemical resistance. Widely used for the preparation of polyurethane rigid foams, medicines and as polyurethane coatings, curing agents for mastic agents, and variously modified isocyanurate-modified compounds have been reported, and for example, CN105073810A, CN109749045A, CN108884082A and the like report the use of variously modified isocyanurate compounds as polymers or oligomers of resist underlayer film forming compositions and the like, rigid foam raw materials and the like.
Disclosure of Invention
The invention mainly aims to provide an oxetane modified isocyanurate compound, a curing composition and application, so as to improve the hardness and flexibility of oxetane products.
In order to achieve the above object, according to one aspect of the present invention, there is provided an oxetane-modified isocyanurate compound having a structure represented by the following general structural formula (I),
Figure BDA0002853135950000011
wherein R is1、R2And R3Each independently selected from H,
Figure BDA0002853135950000021
Any one of (1), R1、R2And R3Not simultaneously being H or R4Is composed of
Figure BDA0002853135950000022
-OH and R1、R2And R3R of (A) to (B)4Not simultaneously being-OH, and R5Each independently is a hydrogen atom, a methyl group or an ethyl group; r6Each independently selected from C1-C20Linear alkylene of (2), C3-C20Any one of the branched alkylene groups of (1), and R6In the main chain-CH2-is optionally substituted by-O-, aryl, provided that two-O-are not directly connected, n is 1 or 2 or 3; r7Selected from ethylene,
Figure BDA0002853135950000023
Figure BDA0002853135950000024
Figure BDA0002853135950000025
Any one of them.
Further, the above R1、R2And R3Each independently selected from
Figure BDA0002853135950000026
Any one of them.
Further, the oxetane-modified isocyanurate compound has any one of the structures represented by the general structural formulae (II) to (IV),
Figure BDA0002853135950000027
Figure BDA0002853135950000031
further, the above R5Each independently of the other being methyl or ethyl, preferably R5Each independently is ethyl.
Further, the above R6Each independently selected from C1-C10Linear alkylene of (2), C3-C10Any one of the branched alkylene groups of (1), and R6In the main chain-CH2-optionally substituted by-O-, aryl, preferably at least R6Second position in the main chain-CH2-is substituted by-O-.
Further, the above R7Selected from ethylene,
Figure BDA0002853135950000032
Figure BDA0002853135950000033
Any one of them.
According to another aspect of the present invention there is provided a curing composition comprising a monomer comprising one or more oxetane-modified isocyanurate compound of any of the above, an initiator.
Further, the curing composition is a photo-curing composition or a thermal-curing composition, and the initiator is a photo-initiator or a thermal initiator.
According to another aspect of the present invention, there is provided a resin product obtained by curing a curing composition, which is any one of the above-mentioned curing compositions.
Further, the resin product is any one of paint, ink, adhesive, optical device, sealing material and photoresist.
By applying the technical scheme of the invention, when the compound with the structural general formula (I) is applied to a curing composition, the hardness and flexibility of a cured product of the curing composition can be improved, and the advantage of excellent adhesive force of the oxetane compound can be maintained. The above-mentioned oxetane-modified isocyanurate compound of the present application can be cured by photo-curing or thermal curing polymerization according to the application environment requirements.
Detailed Description
It should be noted that the embodiments and features of the embodiments in the present application may be combined with each other without conflict. The present invention will be described in detail with reference to examples.
As described in the background of the present application, there is room for improvement in hardness and flexibility of oxetane products, and in order to improve hardness and flexibility of oxetane products, oxetane-modified isocyanurate compounds, curing compositions and uses thereof are provided.
In a typical embodiment of the present application, there is provided an oxetane-modified isocyanurate compound having a structure represented by the following general structural formula (I),
Figure BDA0002853135950000041
wherein R is1、R2And R3Each independently selected from H,
Figure BDA0002853135950000042
Any one of (1), R1、R2And R3Not simultaneously being H or R4Is composed of
Figure BDA0002853135950000043
-any one of OH and R1、R2And R3R of (A) to (B)4Not simultaneously being-OH, and R5Each independently is a hydrogen atom, a methyl group or an ethyl group; r6Each independently selected from C1-C20Linear chain of (2)Alkylene radical, C3-C20Any one of the branched alkylene groups of (1), and R6In the main chain-CH2-is optionally substituted by-O-, aryl, provided that two-O-are not directly connected, n is 1 or 2 or 3; r7Selected from ethylene,
Figure BDA0002853135950000051
Figure BDA0002853135950000052
Figure BDA0002853135950000053
Any one of them.
When the compound with the structural general formula (I) is applied to a curing composition, the hardness and the flexibility of a cured product of the curing composition can be improved, and the advantage of excellent adhesion of an oxetane compound can be maintained. The above-mentioned oxetane-modified isocyanurate compound of the present application can be cured by photo-curing or thermal curing polymerization according to the application environment requirements.
In order to simplify the preparation of the above-mentioned oxetane-modified isocyanurate compound, the above-mentioned R is preferable1、R2And R3Each independently selected from
Figure BDA0002853135950000054
Any one of them.
In some embodiments, the oxetane-modified isocyanurate-based compound has any one of the structures represented by the general structural formulae (II) to (IV),
Figure BDA0002853135950000055
Figure BDA0002853135950000061
in some embodiments, to facilitate oxetane formationModification of isocyanurate with alkane compound, preferably R5Each independently being methyl or ethyl, preferably said R5Each independently is ethyl.
Further, R is preferred for facilitating the modification of isocyanurates with oxetanes6Each independently selected from C1-C10Linear alkylene of (2), C3-C10Any one of the branched alkylene groups of (1), and R6In the main chain-CH2-optionally substituted by-O-, aryl.
Similarly, R is preferably the above-mentioned7Selected from ethylene,
Figure BDA0002853135950000062
Figure BDA0002853135950000063
Any one of them.
The oxetane-modified isocyanurate compound of the present invention may be a single compound or a plurality of compounds having the above general formula may be present at the same time, and in order to facilitate obtaining the above compound by those skilled in the art, an exemplary method for producing the compound is provided below, and the following description is only an exemplary description, and does not mean that the compound of the present invention can be produced by only the following production method.
The compounds of the present application are prepared by reference to the following general scheme:
Figure BDA0002853135950000071
in the above-mentioned production methods, the raw materials used are all known compounds in the prior art, and the type of the solvent used is not particularly limited as long as the raw materials can be dissolved and the reaction is not adversely affected, and dichloroethane, acetonitrile, benzene, toluene, xylene, dimethylformamide (N, N-dimethylformamide) and the like are preferable.
The person skilled in the art can further obtain compounds with different substituents in the general structural formula (I) according to the difference between the raw material b and the raw material c.
The isocyanurate can be modified and substituted to different degrees by adjusting the amount of the raw material b relative to the raw material a, and the molar ratio of the raw material b to the raw material a is preferably 1.0-4.0: 1, in the above range.
Further, the substituent R can be adjusted by adjusting the amount of the raw material c relative to the raw material b5、R6And R7The molar ratio of the raw material c to the raw material b is preferably 1.0-2.0: 1, in the above range.
Furthermore, the compounds of the general structural formulae (II), (III) or (IV) and their mutual proportions can be obtained by adjusting the amount of starting material b relative to starting material c.
The reaction is carried out in two stages, wherein the temperature of the first stage is preferably 80-150 ℃ for 1-5 hours, and the temperature of the second stage is 20-60 ℃ for 10-18 hours.
After the reaction is completed, the resulting reaction solution may be subjected to, for example, solvent extraction or the like, and then the compound of the present invention is isolated. If necessary, it can be purified by washing with a solvent such as water, treating with activated carbon, silica gel chromatography or the like.
The raw material b may be a compound containing a plurality of oxa-functionalities as described below
Figure BDA0002853135950000072
R9Is a m-valent radical selected from C1-C20Straight or branched alkyl of (2), C2-C20Alkenyl of (C)2-C20Cycloalkyl of, C4-C20Cycloalkylalkyl of (C)4-C20Alkylcycloalkyl of C4-C40Optionally, one or more hydrogen atoms of these groups may be independently substituted by a group selected from alkyl, phenyl, halo, nitro, alkoxy, carbonyl; r is8Is represented by C1-C20Alkylene of (a) which is-CH in the main chain2-can renOptionally substituted by an oxygen atom, provided that two-O-groups are not directly attached, optionally one or more hydrogen atoms in these groups may be independently substituted by a group selected from alkyl, halogen, nitro; m is any integer of 1-8.
In another exemplary embodiment of the present application, there is provided a curing composition comprising a monomer comprising one or more oxetane-modified isocyanurate-based compounds of any of the above, an initiator.
When the compound with the structural general formula (I) is applied to a curing composition, the hardness and the flexibility of a cured product of the curing composition can be improved, and the advantage of excellent adhesion of an oxetane compound can be maintained.
The above-mentioned oxetane-modified isocyanurate compound of the present application can be cured by photo-curing or thermal curing polymerization according to the application environment requirements. Thus, the above-mentioned curing composition is a photocurable composition or a thermosetting composition, and the initiator is a photoinitiator or a thermal initiator. The skilled person can select from the initiators used for the conventional initiation of polymerization of oxetanes and will not be described in detail here.
In another exemplary embodiment of the present application, there is provided a resin product obtained by curing a curing composition, which is any one of the above curing compositions. The cured compositions of the present application form resin products having improved hardness and flexibility, thereby improving the application properties of the resin products.
Depending on the properties of the oxetanyl group and the isocyanurate, the above resin product can be applied as any of a coating, an ink, an adhesive, an optical device, a sealing material, and a photoresist.
The present invention will be described in further detail with reference to specific examples, which should not be construed as limiting the scope of the present invention.
Preparation examples
Example 1
Figure BDA0002853135950000091
1-1 preparation:
N2under protection: adding 12.9g of isocyanuric acid, 61.6g of 1-ethyl (3-oxetanyl) methyl glycidyl ether and 50mL of toluene into a 250mL four-neck flask, heating and refluxing at 100 ℃ for 2h, then cooling to room temperature, dropwise adding 30.0g of succinic anhydride, stirring at room temperature overnight, pouring the product system into 50mL of deionized water, stirring and layering to obtain an organic phase and an aqueous phase, then washing the organic phase with water (50 mL multiplied by 5 times) to obtain a washing solution, extracting and combining the washing solution and the aqueous phase with toluene, and after rotary evaporation of the extract, recrystallizing acetonitrile to obtain 45.4g of a light yellow liquid. MS (M/z) 946(M +1)+1H-NMR(CDCl3,500MHz):δ11.89-11.28(s,3H),5.91-5.54(m,9H),4.24-4.14(m,12H),3.90-3.35(m,12H),2.76-2.50(t,12H),1.70-1.65(m,6H),0.89(t,9H)。
1-2 preparation:
the preparation method is the same as the above, the amount of succinic anhydride is changed to 20.0g, and the pale yellow liquid is obtained after recrystallization by 38.5 g. MS (M/z):846(M +1)+1H-NMR(CDCl3,500MHz):δ12.09-11.78(s,2H),5.93-5.46(m,9H),4.38-4.15(m,13H),3.84-3.36(m,12H),2.77-2.53(m,8H),1.72-1.66(m,6H),0.91(t,9H)。
1-3 preparation:
the preparation method is the same as the above, the amount of succinic anhydride is changed to 10.0g, and the light yellow liquid 36.5g is obtained after recrystallization. MS (M/z) 746(M +1)+1H-NMR(CDCl3,500MHz):δ12.03-11.66(s,1H),5.93-5.46(m,9H),4.43-4.16(m,14H),3.76-3.38(m,12H),2.77-2.53(m,4H),1.72-1.67(m,6H),0.85(t,9H)。
Example 2:
Figure BDA0002853135950000101
2-1 preparation:
N2under protection: in a 250mL four-neck flask, 12.9g of isocyanuric acid and 3-ethyl-3- [ [ 3-methoxy ] are added2- (oxyethylene-2-methoxy) propane]Methyl radical]78.0g of oxetane and 50mL of toluene are heated and refluxed at 105 ℃ for 4h, then the temperature is reduced to room temperature, 44.4g of phthalic anhydride is added dropwise, the mixture is stirred at the room temperature overnight, the obtained product system is poured into 50mL of deionized water and stirred and layered to obtain an organic phase and an aqueous phase, then the organic phase is washed with water (50 mL multiplied by 5 times) to obtain a washing solution, the washing solution and the aqueous phase are extracted and combined by toluene, and after the extract is evaporated in a rotary manner, acetonitrile is recrystallized to obtain 42.5g of light yellow liquid. MS (M/z):1396(M +1)+1H-NMR(CDCl3,500MHz):δ13.27-12.89(s,3H),8.20-7.81(m,12H),5.56-5.45(m,3H),4.39-4.14(m,12H),3.92-3.36(m,33H),3.25-3.26(s,9H),1.71-1.68(m,12H),0.87(t,9H)。
2-2 preparation:
the preparation method is the same as the above, the amount of the phthalic anhydride is changed to 29.6g, and 42.3g of light yellow liquid is obtained after recrystallization. MS (M/z):1248(M +1)+1H-NMR(CDCl3,500MHz):δ12.79-13.55(s,2H),7.83-8.22(m,8H),5.54-5.40(m,3H),4.38-4.12(m,13H),3.92-3.35(m,33H),3.27-3.25(s,9H),1.71-1.68(m,12H),0.86(t,9H)。
2-3 preparation:
the preparation method is the same as the above, the amount of the phthalic anhydride is changed to 14.8g, and the light yellow liquid is obtained after recrystallization, wherein the weight of the light yellow liquid is 38.7 g. MS (M/z):1085(M +1)+1H-NMR(CDCl3,500MHz):δ12.79-13.55(s,1H),7.86-8.25(m,4H),5.48-5.37(m,3H),4.38-4.12(m,14H),3.92-3.35(m,33H),3.26-3.23(s,9H),1.71-1.68(m,12H),0.87(t,9H)。
Further, the reaction can be carried out by using different raw materials and different reaction conditions, thereby obtaining compounds with different structures or mixtures in different proportions, but the method is not limited to the following, and the raw materials of examples 3 to 8 are shown in Table 1.
TABLE 1
Figure BDA0002853135950000111
Figure BDA0002853135950000121
Performance evaluation:
preparation of photocured product
TABLE 2
Figure BDA0002853135950000122
Figure BDA0002853135950000131
Resin compositions prepared according to the formulations in examples 9 to 16 and comparative examples 1 to 4 were coated on a glass plate and subjected to a track exposure treatment with a mercury lamp (energy 1000 mj/cm)2) And observing the curing condition, evaluating by a finger touch method, heating to 150 ℃, keeping the temperature for 30min, and testing the application performance of the composition.
Preparation of a thermoset product
TABLE 3
Figure BDA0002853135950000132
The resin compositions prepared according to the formulations of examples 17 to 24 and comparative examples 5 to 8 were stirred at room temperature, coated on a glass substrate, heated at 80 ℃ and observed for the time required for curing, and the application properties of the compositions were tested.
(3) Measurement of hardness
Reference GB T6739-.
(4) Flexibility test
The T-bend performance is tested with reference to GB/T30791-2014.
The evaluation results are recorded in table 4.
TABLE 4
Figure BDA0002853135950000141
From the above description, it can be seen that the above-described embodiments of the present invention achieve the following technical effects: when the oxetane cycloisocyanurate compound of the present invention is used as a raw material of a photocurable compound together with a thermosetting compound, the curing performance is relatively excellent as compared with the case of using a conventional oxetane compound. Further, the cured product obtained from the resin composition has a high crosslinking density and sufficient hardness and flexibility.
The above description is only a preferred embodiment of the present invention and is not intended to limit the present invention, and various modifications and changes may be made by those skilled in the art. Any modification, equivalent replacement, or improvement made within the spirit and principle of the present invention should be included in the protection scope of the present invention.

Claims (10)

1. An oxetane-modified isocyanurate compound characterized by having a structure represented by the following general structural formula (I),
Figure FDA0002853135940000011
wherein R is1、R2And R3Each independently selected from H,
Figure FDA0002853135940000012
Any one of (1), R1、R2And R3Not simultaneously being H, R4Is composed of
Figure FDA0002853135940000013
-any one of OH and R1、R2And R3R of (A)4Not simultaneously being-OH, and R5Each independently is a hydrogen atom, a methyl group or an ethyl group; r6Each independently selected from C1-C20Linear alkylene of (2), C3-C20Any one of the branched alkylene groups of (1), andR6in the main chain-CH2-is optionally substituted by-O-, aryl, provided that two-O-are not directly connected, n is 1 or 2 or 3;
R7selected from ethylene group,
Figure FDA0002853135940000014
Figure FDA0002853135940000015
Figure FDA0002853135940000016
Any one of them.
2. The oxetane-modified isocyanurate compound of claim 1, wherein R is1、R2And R3Each independently selected from
Figure FDA0002853135940000017
Any one of them.
3. The oxetane-modified isocyanurate compound of claim 1 or 2, which has any one of the structures represented by general structural formulae (II) to (IV),
Figure FDA0002853135940000021
4. the oxetane-modified isocyanurate compound of any one of claims 1 to 3, wherein R is5Each independently being methyl or ethyl, preferably said R5Each independently is ethyl.
5. An oxa according to any one of claims 1 to 4A cyclobutane-modified isocyanurate compound, wherein R is6Each independently selected from C1-C10Linear alkylene of (2), C3-C10Any one of the branched alkylene groups of (1), and said R6In the main chain-CH2-optionally substituted by-O-, aryl, preferably at least said R6Second position in the main chain-CH2-is substituted by-O-.
6. The oxetane-modified isocyanurate compound of any one of claims 1 to 5, wherein R is7Selected from ethylene,
Figure FDA0002853135940000031
Figure FDA0002853135940000032
Any one of them.
7. A curing composition comprising a monomer, an initiator, wherein the monomer comprises one or more oxetane-modified isocyanurate compound of any of claims 1 to 6.
8. The cured composition of claim 7, wherein the cured composition is a photocurable composition or a thermally curable composition, and the initiator is a photoinitiator or a thermal initiator.
9. A resin product cured with a curing composition, characterized in that the curing composition is the curing composition according to claims 7 and 8.
10. The resin product according to claim 9, wherein the resin product is any one of a paint, an ink, an adhesive, an optical device, a sealing material, and a photoresist.
CN202011536241.XA 2020-12-22 2020-12-22 Oxetane-modified isocyanurate compound, curing composition and application Active CN114656458B (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
CN202011536241.XA CN114656458B (en) 2020-12-22 2020-12-22 Oxetane-modified isocyanurate compound, curing composition and application
PCT/CN2021/138911 WO2022135275A1 (en) 2020-12-22 2021-12-16 Oxetane-modified isocyanurate compounds, curing composition, and use thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202011536241.XA CN114656458B (en) 2020-12-22 2020-12-22 Oxetane-modified isocyanurate compound, curing composition and application

Publications (2)

Publication Number Publication Date
CN114656458A true CN114656458A (en) 2022-06-24
CN114656458B CN114656458B (en) 2024-03-01

Family

ID=82025153

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202011536241.XA Active CN114656458B (en) 2020-12-22 2020-12-22 Oxetane-modified isocyanurate compound, curing composition and application

Country Status (2)

Country Link
CN (1) CN114656458B (en)
WO (1) WO2022135275A1 (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013163653A (en) * 2012-02-10 2013-08-22 Shikoku Chem Corp Isocyanurate compound having oxetane ring
JP2013163651A (en) * 2012-02-10 2013-08-22 Shikoku Chem Corp Isocyanurate compound having oxetane ring
JP2013163654A (en) * 2012-02-10 2013-08-22 Shikoku Chem Corp Isocyanurate compound having oxetane ring
JP2017132751A (en) * 2016-01-21 2017-08-03 四国化成工業株式会社 Isocyanurate compound having oxetane ring, method for synthesizing the same and use of the isocyanurate compound

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013163653A (en) * 2012-02-10 2013-08-22 Shikoku Chem Corp Isocyanurate compound having oxetane ring
JP2013163651A (en) * 2012-02-10 2013-08-22 Shikoku Chem Corp Isocyanurate compound having oxetane ring
JP2013163654A (en) * 2012-02-10 2013-08-22 Shikoku Chem Corp Isocyanurate compound having oxetane ring
JP2017132751A (en) * 2016-01-21 2017-08-03 四国化成工業株式会社 Isocyanurate compound having oxetane ring, method for synthesizing the same and use of the isocyanurate compound

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
ANNBY, ULF ET AL: "synthesis of new monofunctional and oligofunctional oxetane acetals", 《JOURNAL OF POLYMER SCIENCE, PART A:POLYMER CHEMISTRY》, vol. 39, no. 5, XP055945396, DOI: 10.1002/1099-0518(20010301)39:5<613::AID-POLA1032>3.0.CO;2-0 *

Also Published As

Publication number Publication date
CN114656458B (en) 2024-03-01
WO2022135275A1 (en) 2022-06-30

Similar Documents

Publication Publication Date Title
KR101135771B1 (en) Calixarene compound, process for producing the same, intermediate therefor, and composition thereof
JP6833171B2 (en) Fluorene photoinitiators, methods for producing them, photocurable compositions having them, and use of fluorene photoinitiators in the field of photocuring.
US20020025991A1 (en) Oligomeric and polymeric photosensitizers
CN107344918B (en) Diphenyl ethylene-containing oxime ester compounds and preparation method and application thereof
JP6920488B2 (en) Methods for Producing Stable Thermopolymerizable Vinyl, Amino, or Oligomer Phenoxybenzoxicyclobutene Monomers with Improved Curing Rate
US5073643A (en) High yield synthesis of hydroxyl-containing cationic photoinitiators
US5070117A (en) Aromatic vinyl ether compounds and compositions, and method of making the same
JP2902269B2 (en) Oxetane compounds
US5004842A (en) Aromatic vinyl ether compounds and compositions, and method of making the same
CN112111063A (en) Polysiloxane-containing oxetane monomer and preparation and application thereof
CN109503736A (en) Fluorenes photoinitiator and Photocurable composition comprising it
JP5877507B2 (en) Curing composition having resistance to curing shrinkage, cured product obtained by curing said curable composition, and method
CN109456242B (en) Sulfonium salt photoinitiator, preparation method thereof, photocuring composition containing sulfonium salt photoinitiator and application of photocuring composition
CN114656458A (en) Oxetane-modified isocyanurate compound, curing composition and application
CN107698477B (en) Novel cationic photoinitiator and preparation method and application thereof
CN114716421B (en) Oxetane modified isocyanurates, method for the production thereof, energy-curable compositions and use thereof
JP6861943B2 (en) Anthracene-type compound having a {(3-methyloxetane-3-yl) methyloxy} group, its production method and its use
CN112111062A (en) Silicon-containing monomer containing dioxygen heterocycle and preparation and application thereof
CN114656457B (en) Isocyanurate compound, photo-curable composition, photo-cured product, heat-curable composition and heat-cured product
CN112135817A (en) Monomer comprising at least one 4- (2-oxyethylene) -1, 3-dioxolan-2-one unit and use thereof
JP7344001B2 (en) polymer
WO2021049564A1 (en) Photobase generator, compound, photoreactive composition, and reaction product
JPH11140135A (en) Novel propenyl ether, polymerizable composition and cured product thereof
JP6460701B2 (en) Compound containing structural unit derived from vinyl ether compound
CN116947699A (en) Iodonium salt compound with biphenyl structure, and preparation method and application thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant